...
首页> 外文期刊>American Journal of Physical Medicine and Rehabilitation >Suzuki, M.a , Yamada, S.b , Shimizu, Y.c , Kono, Y.c , Hirashiki, A.d , Izawa, H.e , Murohara, T.d Development of the participation scale for patients with congestive heart failure
【24h】

Suzuki, M.a , Yamada, S.b , Shimizu, Y.c , Kono, Y.c , Hirashiki, A.d , Izawa, H.e , Murohara, T.d Development of the participation scale for patients with congestive heart failure

机译:铃木(M.a),山田(S.b),清水(Y.c),河野(Y.c),平志(A.d),伊泽瓦(Izawa),河村(Murorohara),T.d

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: We report on the development of a participation measure for patients with congestive heart failure (CHF)-the Participation Scale for Patients with CHF (PS-CHF)-and the determination of its unidimensionality, reliability, and validity. DESIGN: This study included two rounds of data collections: 62 patients enrolled in the first round for the purpose of item reduction, and 130 CHF patients and 96 healthy controls participated in the second round for questionnaire validation. RESULTS: The PS-CHF was organized into five items designed to ask about limitations to participation. The PS-CHF score ranges from 5 points (lowest level of participation) to 20 points (highest level of participation). On Rasch analysis, the item calibrations ranged from +0.51 logit for the most difficult item to -0.56 logit for the least difficult item. The range of mean square statistics values was 1.20-0.81 for infit and 1.34-0.72 for outfit. The intraclass correlation coefficient between scores from two successive administrations of the PS-CHF, separated by 2 wks, was 0.94. The total PS-CHF score in CHF patients was significantly lower than in healthy controls. CONCLUSIONS: The PS-CHF was developed to determine a disease-specific participation measure for patients with CHF. The PS-CHF may serve as a clinically meaningful outcome measure for CHF patients.
机译:目的:我们报告了充血性心力衰竭(CHF)患者参与量表(CHF患者的参与量表(PS-CHF))的发展及其单维度,可靠性和有效性的确定。设计:本研究包括两轮数据收集:第一轮纳入62例患者以减少项目,第二轮共130例CHF患者和96名健康对照者进行问卷验证。结果:PS-CHF分为五个项目,旨在询问参与限制。 PS-CHF评分从5分(最低参与水平)到20分(最高参与水平)不等。在Rasch分析中,项目校准的范围从最困难的项目的+0.51 logit到最困难的项目的-0.56 logit。适应度的均方统计值范围为1.20-0.81,服装为1.34-0.72。两次连续两次PS-CHF给药得分之间的组内相关系数为0.94。 CHF患者的总PS-CHF评分显着低于健康对照者。结论:PS-CHF的开发是为了确定CHF患者的疾病特异性参与指标。 PS-CHF可以作为CHF患者临床上有意义的预后指标。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号